Brain Training for Mild Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether brain training can improve memory in individuals with mild cognitive issues related to memory. Researchers will use brain scans to predict who might benefit most from the training. Participants will either engage in a specific brain training program (called TRAIN) or participate in other mentally stimulating computer activities. The trial seeks individuals who have noticed memory changes but can still manage daily tasks independently. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on cognitive health.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but you cannot use antipsychotics, sedatives, or medications with significant anticholinergic properties. Also, you should not use photo-sensitive medications like steroids or retin-A within 15 days of the study.
What prior data suggests that this cognitive training intervention is safe for individuals with mild cognitive impairment?
Research has shown that computerized brain training is generally safe and well-tolerated. Studies have tested this type of training, such as the one used in the TRAIN program, on people with mild memory and thinking problems without major safety concerns. Participants typically perform the exercises on a computer, which includes activities to enhance memory and thinking skills.
In these studies, few side effects were reported. Most participants found the training manageable, experiencing only minor issues like eye strain or tiredness, similar to what one might feel after extended computer use. No serious side effects were reported. This suggests that the brain training used in this trial is likely safe for people with mild cognitive issues.12345Why are researchers excited about this trial?
Researchers are excited about the cognitive training being tested because it offers a non-drug approach to managing mild cognitive impairment. Unlike the standard medications that primarily target symptoms, this method focuses on enhancing brain function through interactive exercises. Delivered via the Posit Science Brain HQ platform, it provides a personalized experience that adapts to individual progress, potentially leading to significant cognitive improvements over time. This tech-driven approach represents a shift towards leveraging digital tools for brain health, making it an innovative option in the field.
What evidence suggests that this cognitive training intervention is effective for mild cognitive impairment?
Research has shown that computer-based brain exercises can improve memory in people with mild cognitive impairment (MCI). In this trial, participants in the intervention group will use a cognitive training program called TRAIN, which involves interactive brain exercises. One study found that an interactive tool for brain exercises was promising for patients with Alzheimer's, a condition similar to MCI. Researchers also found that personalized brain training programs can be effective for people with MCI. These programs boost brain function through specific exercises. Early results suggest that these training methods could help manage MCI symptoms.12356
Who Is on the Research Team?
Joseph M Gullett, PhD
Principal Investigator
University of Florida
Are You a Good Fit for This Trial?
This trial is for older adults with mild cognitive impairment who have a close informant to report on their cognition, can handle daily activities despite some difficulties, and score within normal limits on a cognitive screening. They must not be dependent on certain medications or have conditions like dementia, major psychiatric disturbances, uncontrolled medical issues, or past participation in similar studies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline brain MRI sequences and neuropsychological assessments are conducted
Treatment
Participants undergo cognitive training using the Posit Science Brain HQ Suite for 16 weeks
Follow-up
Participants are monitored for cognitive improvements and changes in UFOV composite score
What Are the Treatments Tested in This Trial?
Interventions
- TRAIN
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
National Institute on Aging (NIA)
Collaborator